Crossmark

Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia

Crossref DOI link: https://doi.org/10.1007/s12035-021-02343-8

Published Online: 2021-03-06

Published Print: 2021-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maes, Michael https://orcid.org/0000-0002-2012-871X
Vojdani, Aristo

Sirivichayakul, Sunee

Barbosa, Decio S.

Kanchanatawan, Buranee
Funding

Funding for this research was provided by:

Asahi Glass Foundation (NA)
License Information

Text and Data Mining valid from 2021-03-06

Version of Record valid from 2021-03-06
More Information

Article History

Received: 22 December 2020

Accepted: 24 February 2021

First Online: 6 March 2021

Declarations

:

: The study was conducted according to Thai and international ethics and privacy laws. Approval for the study was obtained from the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (No. 298/57). All participants and their guardians (parents or other close family members) gave written informed consent prior to participation in this study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below